Melissa Lezameta

Melissa Lezameta is an associate at Epidarex, where they focus on building breakthrough life science companies. With a Ph.D. in Neurobiology from Universitat de Valencia/UCSF, they have a specialized background in oncology and neuroscience, particularly in cancer stem cells and immuno-oncology. Melissa has held various roles, including licensing officer associate at UCSF ITA, postdoctoral researcher at Geron, and owner of ML Bio Consulting, where they supported start-ups and evaluated technologies for licensing. They have also contributed as a board observer for several companies, including Kynos Therapeutics and Macomics, and served as a translation executive at Cancer Research UK.